Literature DB >> 1505720

Growth hormone binding sites in tilapia (Oreochromis mossambicus) liver.

T B Ng1, T C Leung, C H Cheng, N Y Woo.   

Abstract

125I-labeled bovine and tilapia growth hormones were used to assess the presence of growth hormone receptors in membranes prepared from tissues of the tilapia Oreochromis mossambicus. The highest level of specific binding was detected in liver membranes from animals of both sexes and the binding was protein-dependent. Tilapia growth hormone, bovine growth hormone, and ovine prolactin, but not tilapia prolactin, potently inhibited the hepatic binding of 125I-labeled bovine growth hormone. Scatchard analysis of the 125I-labeled bovine growth hormone binding data revealed a Bmax (maximum binding) value of 180 fmol/mg protein and a Kd (dissociation constant) value of 13 nM. Tilapia growth hormone potently inhibited hepatic binding of 125I-labeled tilapia growth hormone. Scatchard analysis revealed a single class of binding sites with Bmax and Kd values of 390 fmol/mg protein and 2.5 nM, respectively. Bovine growth hormone and ovine prolactin were less potent while tilapia prolactin was inactive in inhibiting hepatic 125I-labeled tilapia growth hormone binding.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505720     DOI: 10.1016/0016-6480(92)90132-4

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  2 in total

1.  Characterization of growth hormone binding sites in the goldfish,Carassius auratus: effects of hypophysectomy and hormone injection.

Authors:  Y Zhang; T A Marchant
Journal:  Fish Physiol Biochem       Date:  1996-04       Impact factor: 2.794

2.  Insulin-like growth factor I (IGF-I) in a growth-enhanced transgenic (GH-overexpressing) bony fish, the tilapia (Oreochromis niloticus): indication for a higher impact of autocrine/paracrine than of endocrine IGF-I.

Authors:  Elisabeth Eppler; Antje Caelers; Natallia Shved; Guylin Hwang; Azizur M Rahman; Norman Maclean; Jürgen Zapf; Manfred Reinecke
Journal:  Transgenic Res       Date:  2007-04-13       Impact factor: 3.145

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.